Development of a NanoString assay to detect leukemogenic fusion transcripts in acute myeloid leukemia

Abstract excerpt

INTRODUCTION: Detection of leukemogenic fusion transcripts in acute myeloid leukemia (AML) is critical for AML diagnosis. NanoString nCounter system is a novel probe-based gene expression platform capable of measuring up to 800 targets with advantages of reproducibility, accuracy, and sample type flexibility. To study the potential application of NanoString in leukemia at clinic, we used this technology to detect...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Acute Myeloid Leukemia Research
• Share to Advanced biosensing and bioanalysis techniques
• Share to Retinoids in leukemia and cellular processes